Reading further into this new marker myoinsitol. In the studies within the link I provided. They found a rise in this chemical, affected neurodegenerate disease such as alzhiemers and huntingtons disease, in which, AUSTEDO treats Huntingtons disease. I personally find this an awesome and interesting link, and an obvious area Dr Stamler is very privy too given his alterations and apporal of AUSTEDO.
If he can get AUSTEDO to market, he sure can get ATH434 to market, so glad I found this gem of a stock.
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-164
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
